OCT 30-31 ♦ ORLANDO, FL
DAYS OF CONFERENCE
YEARS OF PPA
10:00 AM - 5 PM: CONFERENCE
6 PM - 8 PM: STRONGBRIDGE DINNER PROGRAM
8:30 AM - 1 PM: DOCTOR Q+A
Sunday is Halloween. We encourage EVERYONE to dress in costume for the day!
Due to the number of attendees and social distancing guidelines, we are now located in a larger room that provides adequate space for social distancing. *Please note this room does not provide natural lighting.
We will adhere to all COVID-19 precautions that are in place at the time of the conference by the CDC and the state of Florida.
MEET THE DOCTORS
Stephen Cannon, MD, PhD.
Dr. Cannon is a recognized authority on channelopathies and neuromuscular disorders. His contributions to this and related fields include numerous articles, and book chapters, and a commitment to education, clinical practice, and research.
Rabi Tawil, MD, PhD.
As a clinical researcher, Dr. Tawil’s focus on the clinical manifestations and treatment of the periodic paralyses. His research led to the recognition of the Andersen-Tawil Syndrome (ATS) as a distinct form of periodic paralysis.
William Harr DNP, CRNA
Dr. William Harr has a Bachelor of Arts in Business Management, a Doctor of Science in Nursing, and is a Board Certified, Registered Nurse Anesthetist. Mr. Harr is currently completing his Doctor of Nursing studies at Lourdes University with a focus on translating research into clinical practice for safer anesthesia for periodic paralysis patients.
Miguel Chuquilin Arista, MD, FAAN
Dr. Chuquilin is board-certified in neurology, neuromuscular medicine and electrodiagnostic medicine. At the University of Florida, he currently serves as the Neurology Clerkship and Neuromuscular Fellowship Director.
Frequently Asked Questions
Yes. We understand everyone’s concerns with cold triggers. We will make sure that the temperature of the room is comfortable for all our guests. As well, we encourage you to wear your most comfortable clothes and bring your coziest blankets!
HELP US DISCOVER ANSWERS WE ARE ALL SEEKING.
Your contribution helps fund ongoing Periodic Paralysis research and the discovery of new mutations and possible new treatments.